Arcutis Biotherapeutics, Inc. Contracts & Agreements

Second Amendment to Amended and Restated Loan and Security Agreement, dated (Filed With SEC on August 14, 2024)

First Amendment (Filed With SEC on May 14, 2024)

Underwriting Agreement, dated February 28, 2024, by and among Arcutis Biotherapeutics, Inc. and (Filed With SEC on March 4, 2024)

Amendment Employment Agreement, dated February 22, 2024, by and between the Registrant and Matthew R. Moore (Filed With SEC on February 27, 2024)

Form of Pre-Funded Warrant (Filed With SEC on October 23, 2023)

Underwriting Agreement, dated October 19, 2023, by and among Arcutis Biotherapeutics, Inc. and Morgan Stanley & Co. LLC, Cowen and Company, LLC and Guggenheim Securities, LLC, as... (Filed With SEC on October 23, 2023)

Form of Non-Employee Director RSU Deferral Election (Filed With SEC on February 28, 2023)

Non-Employee Director Compensation Program (Filed With SEC on February 28, 2023)

Amended and Restated (Filed With SEC on February 28, 2023)

Underwriting Agreement, dated August 2, 2022, by and among Arcutis Biotherapeutics, Inc. and Morgan Stanley & Co. LLC, Cowen and Company, LLC and Guggenheim Securities, LLC, as... (Filed With SEC on August 5, 2022)

2022 Employment Inducement Incentive Plan and forms of award (Filed With SEC on February 22, 2022)

Offer Letter, dated (Filed With SEC on February 22, 2022)

Loan and Security Agreement, dated December 22, 2021, by and among the Registrant, SLR Investment Corp. and the lenders party (Filed With SEC on February 22, 2022)

Severance & Change in Control Agreement, by and between the Registrant and Mas Matsuda (Filed With SEC on February 22, 2022)

Supply and Manufacturing Agreement, dated September 15, 2021, between DPT Laboratories, Ltd. and the Registrant (Filed With SEC on November 4, 2021)

Sales Agreement, dated May 6, 2021, by and between the Registrant and Cowen and Company, LLC (Filed With SEC on May 6, 2021)

Severance & Change in Control Agreement, by and between the Registrant and Scott L. Burrows (Filed With SEC on May 6, 2021)

Exclusive Distribution Agreement, dated February 8, 2021, by and between the Registrant and Cardinal Health 105, Inc (Filed With SEC on May 6, 2021)

Severance & Change in Control Agreement, by and between the Registrant and Matthew R. Moore (Filed With SEC on February 16, 2021)

Offer Letter, dated December 18, 2020, by and between the Registrant and Matthew (Filed With SEC on February 16, 2021)

Supply Agreement, dated November 24, 2020, by and between Registrant and Interquim, S.A (Filed With SEC on February 16, 2021)

Underwriting Agreement, dated February 2, 2021, by and among Arcutis Biotherapeutics, Inc. and (Filed With SEC on February 5, 2021)

Registration Rights Agreement, dated October 1, 2020, by and among Arcutis Biotherapeutics, Inc. and the purchasers named therein (Filed With SEC on October 6, 2020)

Securities Purchase Agreement, dated October 1, 2020, by and among Arcutis Biotherapeutics, Inc. and the purchasers named therein (Filed With SEC on October 6, 2020)

Form of Underwriting Agreement (Filed With SEC on September 29, 2020)

First Amendment to Office Lease Agreement, dated April 22, 2020, by and between Registrant and Westlake Park Place, Inc (Filed With SEC on August 11, 2020)

Office Lease Agreement, dated January 31, 2019, by and between the Registrant and Westlake Park Place, Inc (Filed With SEC on August 11, 2020)

Offer Letter, dated July (Filed With SEC on July 29, 2020)

Severance & Change in Control Agreement, dated July 28, 2020, by and between Arcutis Biotherapeutics, Inc. and Patrick Burnett (Filed With SEC on July 29, 2020)

Description of Arcutis Biotherapeutics Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 19, 2020)

Severance & Change in Control Agreement, by and between the Registrant and Kenneth A. Lock, to become effective on the date the registration statement is declared effective (Filed With SEC on January 21, 2020)

Form of Underwriting Agreement (Filed With SEC on January 21, 2020)

Form of Common Stock Certificate (Filed With SEC on January 21, 2020)

2020 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on January 21, 2020)

2020 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on January 21, 2020)

Offer Letter, dated January 9, 2020, by and between the Registrant and Todd Franklin Watanabe, to become effective on the date immediately prior to the date the registration... (Filed With SEC on January 21, 2020)

Offer Letter, dated January 9, 2020, by and between the Registrant and David W. Osborne, to become effective on the date immediately prior to the date the registration statement... (Filed With SEC on January 21, 2020)

Offer Letter, dated January 9, 2020, by and between the Registrant and Howard G. Welgus, M.D., to become effective on the date immediately prior to the date the registration... (Filed With SEC on January 21, 2020)

Offer Letter, dated January 9, 2020, by and between the Registrant and John W. Smither, to become effective on the date immediately prior to the date the registration statement is... (Filed With SEC on January 21, 2020)

Offer Letter, dated January 9, 2020, by and between the Registrant and Kenneth A. Lock, to become effective on the date immediately prior to the date the registration statement is... (Filed With SEC on January 21, 2020)

Offer Letter, dated January 9, 2020, by and between the Registrant and Patricia A. Turney, to become effective on the date immediately prior to the date the registration statement... (Filed With SEC on January 21, 2020)

Severance & Change in Control Agreement, by and between the Registrant and Todd Franklin Watanabe, to become effective on the date the registration statement is declared effective (Filed With SEC on January 21, 2020)

Severance & Change in Control Agreement, by and between the Registrant and David W. Osborne, to become effective on the date the registration statement is declared effective (Filed With SEC on January 21, 2020)

Severance & Change in Control Agreement, by and between the Registrant and Howard G. Welgus, M.D., to become effective on the date the registration statement is declared effective (Filed With SEC on January 21, 2020)

Severance & Change in Control Agreement, by and between the Registrant and John W. Smither, to become effective on the date the registration statement is declared effective (Filed With SEC on January 21, 2020)

Severance & Change in Control Agreement, by and between the Registrant and Patricia A. Turney, to become effective on the date the registration statement is declared effective (Filed With SEC on January 21, 2020)

Amended and Restated Investors Rights Agreement, dated October 8, 2019, by and among the Registrant and certain of its stockholders (Filed With SEC on January 6, 2020)

Form of Indemnity Agreement (Filed With SEC on January 6, 2020)

2017 Stock Incentive Plan, and forms of award agreements (Filed With SEC on January 6, 2020)

2020 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on January 6, 2020)

2020 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on January 6, 2020)

Consulting Agreement, dated August 16, 2016, by and between Bhaskar Chaudhuri and the Registrant (Filed With SEC on January 6, 2020)

License Agreement, dated July 23, 2018, by and between AstraZeneca AB and the Registrant (Filed With SEC on January 6, 2020)

Exclusive Option and License Agreement, dated January 4, 2018, by and between Jiangsu Hengrui Medicine Co., Ltd. and the Registrant (Filed With SEC on January 6, 2020)

Collaboration Agreement, dated June 28, 2019, by and between Hawkeye Therapeutics, Inc. and the Registrant (Filed With SEC on January 6, 2020)

Transition and Amendment Agreement, dated December 13, 2019 by and between Bhaskar Chaudhuri and the Registrant (Filed With SEC on January 6, 2020)

Option Notice and Amendment No. 2 to Exclusive Option and License Agreement, dated December 5, 2019, by and between Jiangsu Hengrui Medicine Co., Ltd. and the Registrant (Filed With SEC on January 6, 2020)

Form of Severance & Change in Control Agreement (Filed With SEC on January 6, 2020)

Category

Industry

Companies

Contracts

Arcutis Biotherapeutics, Inc. Contracts & Agreements